These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35432585)

  • 1. Study on the Mechanism of Action of Paclitaxel-Loaded Polylactic-co-glycolic Acid Nanoparticles in Non-Small-Cell Lung Carcinoma Cells.
    Zuo Y; Shen W; Wang L; Wang C; Pu J
    Comput Math Methods Med; 2022; 2022():8524951. PubMed ID: 35432585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
    Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
    Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
    Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
    Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Effects of Paclitaxel Loaded Polyethylene Glycol-Polylactic Acid-Glycolic Acid Copolymer Nanoparticles on Pancreatic Cancer in Rats.
    Fu Y; Tan L; Meng L; Lei X
    J Nanosci Nanotechnol; 2020 Dec; 20(12):7271-7275. PubMed ID: 32711590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma.
    Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P
    J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
    Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
    Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination nanochemotherapy of brain tumor using polymeric nanoparticles loaded with doxorubicin and paclitaxel: An in vitro and in vivo study.
    Malekpour MR; Hosseindoost S; Madani F; Kamali M; Khosravani M; Adabi M
    Eur J Pharm Biopharm; 2023 Dec; 193():175-186. PubMed ID: 37926270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
    Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated multi-omics analysis reveals unique signatures of paclitaxel-loaded poly(lactide-co-glycolide) nanoparticles treatment of head and neck cancer cells.
    Haider M; Jagal J; Bajbouj K; Sharaf BM; Sahnoon L; Okendo J; Semreen MH; Hamda M; Soares NC
    Proteomics; 2023 Aug; 23(16):e2200380. PubMed ID: 37148169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.
    Diab T; Alkafaas SS; Shalaby TI; Hessien M
    Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
    Wang Y; Li Q; Zhou JE; Tan J; Li M; Xu N; Qu F; Chen J; Li J; Wang J; Liang Z; Yu L; Wang Y; Yan Z
    Pharm Res; 2021 Apr; 38(4):669-680. PubMed ID: 33796952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic targeting of paclitaxel-loaded poly(lactic-
    Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
    Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
    Gullotti E; Park J; Yeo Y
    Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.